Determination of A 3,4-diaminopyridine in plasma by liquid chromatography with electrochemical detection using solid-phase extraction

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 805, Issue 2, 2004, Pages 261-266

  Goulay Dufay S ^a   Do, B ^a   Le Hoang, M D ^a   Raust, J A ^a   Graffard, H ^a   Guyon, F ^a   Pradeau, D ^a  

^a AGEPS   (France)

Author keywords

3,4 Diaminopyridine

Indexed keywords

CARTILAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVING SYSTEMS STUDIES; QUALITY CONTROL;

A 3,4-DIAMINOPYRIDINE; ANIMAL PLASMAS; INTERNAL STANDARD (IS); SOLID-PHASE EXTRACTION (SPE);

AMINES;

3,4 DIAMINOPYRIDINE; PHENYLEPHRINE;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOG; DRUG CLEARANCE; DRUG DETERMINATION; ELECTROCHEMICAL ANALYSIS; EXPERIMENTAL MODEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; SOLID PHASE EXTRACTION; TOXICOKINETICS;

4-AMINOPYRIDINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; ELECTROCHEMISTRY; FEMALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS;

EID: 2342513462     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.03.010     Document Type: Article

References (18)

1. Lundh H., Nilsson O., Rosén I., Johansson S. Acta Neurol. Scand. 88:1993;136
2. McEvoy K.M., Windebank A.J., Daube J.R., Low P.A. N. Engl. J. Med. 321:1989;1567
3. Lundh H., Nilsson O., Rosén I. Prog. Brain Res. 84:1990;163
4. Sanders D.B., Howard J.F., Massey J.M. Ann. NY Acad. Sci. 681:1993;588
5. Bevers C.T., Anderson P.A., Leslie J., Panitch H.S., Dhib-Jalbut S., Kahn O.A., et al. Neurology. 47:1996;1457
6. Lundh H., Nilsson O., Rosén I. Neurology. 34:1984;1324
7. Leslie J., Bever C.T. J. Chromatogr. 496:1989;214
8. Kamali F., Nicholson E.J. J. Pharm. Biomed. Anal. 13:1995;791
9. van der Horst A., de Goede P.N., van Dieman H.A., Polman C.H., Martens H.J. J. Chromatogr. 574:1992;166
10. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., et al. STP Pharma Pratiques. 7:1997;169
11. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., et al. STP Pharma Pratiques. 8:1998;81
12. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., et al. STP Pharma Pratiques. 10:2000;21
13. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., et al. STP Pharma Pratiques. 2000:2000;79
14. International Conferences on Harmonisation 4, Quality 2A, Note for Guidance on Validation of Analytical Methods: Definitions and Terminology, 1994.
15. International Conferences on Harmonisation 4, Quality 2B, Note for Guidance on Validation of Analytical Procedure: Methodology, 1996.
16. Rasala D. Bull. Soc. Chim. Fr. 129:1992;79
17. K Florey (Ed.), Analytical Profiles of Drug Substances, Academic Press, New York, 1974, p. 483.
18. Bever C.T., Leslie J., Camenga D.L., Panitch H.S., Johnson K.P. Ann. Neurol. 27:1990;421